Lodged with the ASX under Listing Rule 4.3A This Preliminary final report should be read in conjunction with the 30 June 2014 Annual Report...
QRxPharma Provides Feedback On End-of-Review Meeting With The FDA On Moxduo® PR Newswire SYDNEY and BEDMINSTER, N.J., July 11, 2014 SYDNEY and...
QRxPharma Announces Board Resignations PR Newswire SYDNEY and BEDMINSTER, N.J., July 9, 2014 SYDNEY and BEDMINSTER, N.J., July 9, 2014...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.